Genetic LifeSpan debuts IMUN cell banking at Celularity site

Genetic LifeSpan marked the premiere of its IMUN personal cell banking service at Celularity’s Florham Park, New Jersey facility during an invitation-only event for about 60 guests. The launch underscores the company’s push into immune cell banking, while Celularity provides processing, testing, cryopreservation and storage support for the program.

Why it matters: - IMUN gives Genetic LifeSpan a consumer-facing entry into personal immune cell banking. - The program depends on Celularity’s cryopreservation and storage infrastructure in Florham Park, New Jersey. - Genetic LifeSpan is positioning IMUN around future cell storage, while Celularity’s role is limited to processing and storage support.

What happened: - Genetic LifeSpan announced the premiere of IMUN, its personal cell banking service, at an invitation-only event at Celularity’s New Jersey facility. - The event took place at Celularity’s Florham Park site. - About 60 invited guests attended. - Guests toured portions of the facility and learned about the IMUN program.

The details: - Celularity provides certain cell-processing, testing, cryopreservation and storage services for the IMUN program. - Celularity is a biotechnology company focused on cellular and regenerative medicine. - The Florham Park facility supports Celularity’s investigational cellular medicine platform, biobanking services and related operations. - Genetic LifeSpan founder and CEO Adam Vincent Gilmer said selecting the right banking partner was critical to the IMUN vision. - Gilmer said Celularity brings expertise, purpose-built infrastructure and experience in cellular cryopreservation. - Gilmer said the facility visit gave guests a meaningful introduction to where cells collected through IMUN would be processed and stored. - IMUN is offered and administered exclusively by Genetic LifeSpan. - Celularity does not offer, market or sell IMUN. - Celularity does not make any representation about participation suitability, future availability or utility of stored cells, or any potential therapeutic or clinical use. - Participation in IMUN does not ensure that stored cells will be suitable or available for future medical use. - The announcement included Genetic LifeSpan social media links on LinkedIn, Instagram, Facebook, YouTube and TikTok.

Between the lines: - The event looks designed to build trust by letting invited guests see the handling and storage environment in person. - The repeated disclaimers make clear Celularity is a service provider, not the seller or promoter of IMUN. - Genetic LifeSpan is emphasizing infrastructure and control over the customer experience as it introduces the program.

What's next: - Genetic LifeSpan is likely to continue rolling out IMUN through its own sales and administration channels. - Celularity will continue providing the back-end processing and storage functions tied to the program. - The company may use the premiere event and facility access to support future awareness efforts around IMUN.